INS and Insulin resistance: The administration of insulin sensitizers, such as metformin and rosiglitazone, which were proposed in PCOS patients to improve ovulation induction and metabolic parameters, increased serum Hcy levels in patients with type 2 diabetes mellitus, despite the decrease in insulin resistance (53).